Randomized phase 2a study of TAS5315, a Bruton’s tyrosine kinase inhibitor, for chronic spontaneous urticaria

American Journal of Emergency Medicine · Elsevier

Аннотация

Publication date: Available online 14 July 2026 Source: Allergology International Author(s): Michihiro Hide, Atsushi Fukunaga, Koremasa Hayama, Naoko Inomata, Shunsuke Takahagi, Tokuya Omi, Masaru Igarashi, Ryuji Maruyama, Akiko Yagami

Читать у издателя →

Похожие статьи